Focus on fluvastatin: The first totally synthetic HMG-CoA reductase inhibitor for treatment of hypercholesterolemia

Authors
Category Primary study
JournalHospital Formulary
Year 1994
This article has no abstract
Epistemonikos ID: a7812811a1508c230480ceb9a7372105951ca00e
First added on: Feb 03, 2025